Heterocyclic GPR40 modulators

Details for Australian Patent Application No. 2007293028 (hide)

Owner Amgen Inc.

Inventors Lai, Sujen; Kohn, Todd J.; Dransfield, Paul; Jiao, Xianyun; Liu, Jinqian; Schmitt, Michael J.; Vimolratana, Marc; Shen, Wang; Sharma, Rajiv; Medina, Julio C.; Houze, Jonathan; Beck, Hilary; Liu, Jiwen; Ma, Zhihua; Fu, Zice; Wang, Yingcai; Wang, Zhongyu

Agent Shelston IP

Pub. Number AU-B-2007293028

PCT Pub. Number WO2008/030520

Priority 60/843,262 07.09.06 US; 60/857,665 07.11.06 US; 60/923,437 13.04.07 US

Filing date 6 September 2007

Wipo publication date 13 March 2008

Acceptance publication date 31 May 2012

International Classifications

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/030520 Priority application(s): WO2008/030520

31 May 2012 Application Accepted

  Published as AU-B-2007293028

12 July 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Shen, Wang; Liu, Jiwen; Fu, Zice; Sharma, Rajiv; Wang, Yingcai; Liu, Jinqian; Houze, Jonathan; Schmitt, Michael J.; Kohn, Todd J.; Wang, Zhongyu; Beck, Hilary; Jiao, XianYun; Lai, SuJen; Dransfield, Paul; Vimolratana, Marc; Ma, Zhihua; Medina, Julio C. . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

1 November 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Shen, Wang; Liu, Jiwen; Fu, Zice; Sharma, Rajiv; Wang, Yingcai; Liu, Jinqian; Houze, Jonathan; Schmitt, Michael J.; Kohn, Todd J.; Wang, Zhongyu; Beck, Hilary; Jiao, XianYun; Lai, SuJen; Dransfield, Paul; Vimolratana, Marc; Ma, Zhihua and Medina, Julio C.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293032-Liquid pharmaceutical formulations for oral administration of a CGRP antagonist

2007293025-Nickel-titanium alloy including a rare earth element